| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |